Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The good news keeps flowing, but the share price continues to drop. The ambition here is big and given the appointment and his worldwide knowledge you have to believe this is going to grow rapidly at some point.
DALLAS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI)
(“Spectral AI” or the “Company”), an artificial intelligence (AI)
company focused on medical diagnostics for faster and more accurate treatment
decisions in wound care, today announced the appointment of Prof. Paul
Chadwick as Executive Vice President of the Company’s United Kingdom
subsidiary. Prof. Chadwick is an experienced clinical scientist and wound care
key opinion leader (KOL) with an impressive body of work including a
substantial and impactful publication record, particularly in the domain of
diabetic wound management. He will be responsible for the international market
expansion of the Company’s DeepView(®) wound imaging technology in the
United Kingdom, Europe, Middle East and Africa (EMEA), all of which are
geographic areas where Prof. Chadwick has extensive clinical networks,
significant experience and has enjoyed previous successes.
“Paul brings over fifteen years of invaluable expertise in the medical
devices and technology sectors to our team. The Royal College of Podiatry is
an extremely prestigious and important organization where Paul most recently
served for over six years in senior executive capacities, including CEO. We
are highly confident that his addition will significantly enhance our efforts
in advancing the widespread adoption of the DeepView(®) System,” said Niko
Pagoulatos, the Company’s COO. “Spectral AI continues to strengthen its
leadership team and Paul’s experience in diabetic foot ulcers and clinical
wound management will contribute to our growth and enhance our capacity to
innovate.”
Prof. Chadwick’s impressive journey stretches across clinical, academic and
business disciplines. In his previous roles at the Royal College of Podiatry,
Prof. Chadwick led all the clinical, educational and financial aspects of the
organization. In addition, he has held multiple leadership positions such as
consultant podiatrist at The National Health Service (NHS), and Managing
Director at Curativo Wound Care Consultancy, where he has served companies
such as 3M, Molnlycke Health Care, Smith & Nephew, Advancis, Thornton & Ross,
Essity and many others. In his capacity as a prominent authority in wound
care, Prof. Chadwick fulfills critical roles on advisory boards and
exemplifies best practices in the field. Furthermore, he generously imparts
his knowledge as an adjunct professor at Birmingham City University, where he
teaches in the Health and Life Sciences Department.